Almudena Torres Cornejo

Almudena Torres Cornejo

Harvard University - Cambridge / United States
Medical and Health Sciences / Infectious Diseases
AD Scientific Index ID: 1349813
person_outline Almudena Torres Cornejo's MOST POPULAR ARTICLES
1-) Benefits from sustained virologic response to pegylated interferon plus ribavirin in HIV/hepatitis C virus–coinfected patients with compensated cirrhosisJA Mira, A Rivero-Juárez, LF López-Cortés, JA Girón-González, F Téllez, ...Clinical Infectious Diseases 56 (11), 1646-1653, 20131092013
2-) Differentiation of exhausted CD8+ T cells after termination of chronic antigen stimulation stops short of achieving functional T cell memoryP Tonnerre, D Wolski, S Subudhi, J Aljabban, RC Hoogeveen, ...Nature immunology 22 (8), 1030-1041, 2021612021
3-) Early transcriptional divergence marks virus-specific primary human CD8+ T cells in chronic versus acute infectionD Wolski, PK Foote, DY Chen, LL Lewis-Ximenez, C Fauvelle, J Aneja, ...Immunity 47 (4), 648-663. e8, 2017602017
4-) Prediction of response to pegylated interferon plus ribavirin in HIV/hepatitis C virus (HCV)-coinfected patients using HCV genotype, IL28B variations, and HCV-RNA loadK Neukam, A Camacho, A Caruz, N Rallón, A Torres-Cornejo, ...Journal of hepatology 56 (4), 788-794, 2012552012
5-) Liver toxicity associated with antiretroviral therapy including efavirenz or ritonavir-boosted protease inhibitors in a cohort of HIV/hepatitis C virus co-infected patientsK Neukam, JA Mira, J Ruiz-Morales, A Rivero, A Collado, ...Journal of antimicrobial chemotherapy 66 (11), 2605-2614, 2011342011